p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium

Annals of Diagnostic Pathology

Volumn 10, Issue 4, 2006, Pages 193-196

  Horn, Lars Christian ^a   Richter, Christine E ^a   Einenkel, Jens ^a   Tannapfel, Andrea ^a   Liebert, Uwe Gerd ^a   Leo, Cornelia ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Endometrium; HPV; p14; p16; p53; Pathogenesis; Squamous cell carcinoma; Steroid hormone receptors

Indexed keywords

ANDROGEN RECEPTOR; CYCLIN D1; CYTOPLASM PROTEIN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P14; PROTEIN P16; PROTEIN P53; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; WART VIRUS;

ADULT; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, STEROID; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745862424     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2005.09.001     Document Type: Article

References (29)

1. Batchelor F.C., and Doran A. Primary squamous celled epithelioma of the body of the uterus. Trans Obstet Soc 45 (1903) 374-380
2. Rodolakis A., Papaspyrou I., Sotiropoulou M., Markaki S., and Michalas S. Primary squamous cell carcinoma of the endometrium. A report of three cases. Eur J Gynaecol Oncol 22 (2001) 143-146
3. Creasman W.T., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Heintz A.P.M., et al. Carcinoma of the corpus uteri. FIGO annual report on the results of treatment in gynecological cancer, vol. 25. Int J Gynecol Obstet 83 (2003) 79-118
4. Silverberg S.G., Kurman R.J., Nogales F., Mutter G.L., Kubik-Huch R.A., and Tavassoli F.A. Epithelial tumors and related lesions of the uterine corpus. In: Tavassoli F.A., and Devilee P. (Eds). Tumours of the breast and female genital tract. World Health Organization Classification of Tumours (2003), IARC Press, Lynon 217-257
5. Clement P.B., and Young R.H. Non-endometrioid carcinoma of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 11 (2004) 117-142
6. Zidi Y.S.H., Boraoui S.W., Atallah K., Kchir N., and Haouet S. Primary in-situ squamous cell carcinoma of the endometrium with extensive squamous metaplasia and dysplasia. Gynecol Oncol 88 (2003) 444-446
7. O'Leary J.J., Landers R.J., Crowley M., Healy I., O'Donovan M., Healy V., et al. Human papillomavirus and mixed epithelial tumors of the endometrium. Hum Pathol 29 (1998) 309-310
8. Koh J., Enders G.H., Dynlacht B.D., and Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375 (1995) 506-510
9. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Surg Pathol 153 (1998) 1741-1748
10. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
11. Lowe S.W., and Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13 (2003) 77-83
12. Bradley G., Irish J., MacMillan C., Mancer K., Witterick I., Hartwick W., et al. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Oncogene 20 (2001) 654-658
13. Cao Q.J., Einstein M.H., Anderson P.S., Runowicz C.D., Balan R., and Jones J.G. Expression of COX-2, cyclin D1 and p21 in endometrial endometrioid carcinomas. Int J Gynecol Pathol 21 (2002) 147-154
14. Ruhul-Quddus M., Latkovich P., Castellani W.J., Sung J.C., Steinhoff M.M., Briggs R.C., et al. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinomas suggesting a role in endometrial carcinogenesis. Arch Pathol Lab Med 126 (2002) 459-463
15. Lax S.F. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virch Arch 444 (2004) 213-223
16. Horn L.C., Fischer U., Hänel C., Kuhn H., Raptis G., and Bilek K. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread. Pathol Res Pract 197 (2001) 605-609
17. Tannapfel A., Benicke M., Katalinic A., Uhlmann D., Hauss J., and Wittekind C. Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47 (2000) 721-727
18. Bae D.S., Cho S.B., Kim Y.J., Whang J.D., Song S.Y., Park C.S., et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical carcinoma of the uterus. Gynecol Oncol 81 (2001) 341-347
19. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thürlimann B., and Senn H.J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21 (2003) 1-9
20. Horn L.C., Edelmann J., Hähnel C., Fischer U., Müller A., and Höckel M. Identity testing in cervical carcinoma in case of suspected mix-up. Int J Gynecol Pathol 19 (2000) 387-389
21. +/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35 (1997) 791-795
22. + primer sets. J Clin Virol 30 (2004) 302-308
23. Lininger R.A., Wistuba I., Gazdar A., Koenig C., Tavassoli F.A., and Albores-Saavedra J. Human papillomavirus type 16 is detected in transitional cell carcinomas and squamotransitional cell carcinomas of the cervix and endometrium. Cancer 83 (1998) 521-527
24. Czerwenka K., Lu Y., Heuss F., Manavi M., and Kubista E. Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus. Gynecol Oncol 61 (1996) 210-214
25. Kataoka A., Hishida T., Sugiyama T., Hori K., Honda S., and Yakushiji M. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol 65 (1997) 180-184
26. Breuer R.H., Snijders P.J., Sutedja G.T., Sewalt R.G., Otte A.P., Postmus P.E., et al. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung Cancer 48 3 (2005) 299-306
27. Semczuk A., Miturski R., Skomra D., and Jakowicki J.A. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and CDK4) in human endometrial cancer: correlation with clinicopathologic features. Arch Gynecol Obstet 269 (2004) 104-110
28. Horn L.C., Lax S.F., Höckel M., Fischer U., and Schmidt D. Precancerous lesions of the endometrium: a review of the molecular pathogenesis and problems in terminology. Geburtsh Frauenheilk 61 (2001) 8-14
29. Im D.D., Shah K.V., and Rosenshein N.B. Report of three new cases of squamous carcinoma of the endometrium with emphasis in the HPV status. Gynecol Oncol 56 3 (1995) 464-469